Alnylam Pharmaceuticals
ALNY
#709
Rank
โ‚ฌ31.17 B
Marketcap
233,48ย โ‚ฌ
Share price
-1.61%
Change (1 day)
-15.49%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) Fails to deliver data

Key failure to deliver metrics for Alnylam Pharmaceuticals :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Alnylam Pharmaceuticals (ALNY) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Alnylam Pharmaceuticals (ALNY) - since 2013

Volume in USD (price x number of shares), data since 2013

Alnylam Pharmaceuticals (ALNY) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026โ‚ฌ23.79 M-44.43%
2025โ‚ฌ42.8 M-0.86%
2024โ‚ฌ43.18 M-16.96%
2023โ‚ฌ51.99 M-66.55%
2022โ‚ฌ0.15 B200.46%
2021โ‚ฌ51.74 M-9.83%
2020โ‚ฌ57.38 M52.34%
2019โ‚ฌ37.66 M46.52%
2018โ‚ฌ25.7 M-70.97%
2017โ‚ฌ88.54 M191.96%
2016โ‚ฌ30.32 M-14.94%
2015โ‚ฌ35.65 M68.07%
2014โ‚ฌ21.21 M152.1%
2013โ‚ฌ8.41 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Novartis
NVS
โ‚ฌ59.4 Mโ‚ฌ0.41 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
โ‚ฌ6.03 Mโ‚ฌ23.87 M๐Ÿ‡ซ๐Ÿ‡ท France
Regeneron Pharmaceuticals
REGN
โ‚ฌ2.02 Mโ‚ฌ22.63 M๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚ฌ12.05 Mโ‚ฌ24.23 M๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
N/Aโ‚ฌ0.19 M๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
โ‚ฌ0.87 Mโ‚ฌ2.11 M๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ5.85 Mโ‚ฌ80.51 M๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Arrowhead Pharmaceuticals
ARWR
โ‚ฌ0.22 Bโ‚ฌ0.24 B๐Ÿ‡บ๐Ÿ‡ธ USA